
Overview
Genvita is a biotechnology company that develops and creates biodegradable materials for medical applications, including partially biodegradable medical masks designed to protect against viruses and bacteria. The company also focuses on innovative biotechnological and agrotechnical solutions for the textile and herbal industries, as well as the cultivation of new plant species. Their products are intended for distribution to pharmaceutical wholesalers, pharmacies, and hospitals.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 29 days early.
- 202511/07/2026
- 202424/06/2025
- 202329/06/2024
- 202223/06/2023
- 202129/06/2022
- 202015/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Rafał Andrzej Perz age 40 | 30 | $405.19 | 30% |
Joanna Ratajczak age 38 | 70 | $945.43 | 70% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-06-11.
97 1050 1025 1000 0090 3220 8051
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 24, 2022 | Aid for research and development projects: industrial research | $316.2K$316,222 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jan 24, 2022 | Aid for research and development projects: experimental development | $140.9K$140,854 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Jan 24, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $52,349$52,349 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-10-01 | Development of a biodegradable type II mask made of natural fibers | $1.2M$1,208,838 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Balton sp. z o.o. | $40,937,638.93 | balton.pl | ||
| Dina-Hitex Polska sp. z o.o. | $3,582,181.68 | dina-hitex.pl | ||
| Airway Medix S.A. | $2,991,210.45 | airway-medix.com | ||
| Metzer Medizin- Und Industrietechnik sp. z o.o. | $1,511,723.18 | metzer.pl | ||
| Mustaf Medical sp. z o.o. | $1,215,507.17 | mustaf-medical.pl | ||
| Fabre sp. z o.o. | $958,540.36 | fabre.com.pl | ||
| Przedsiębiorstwo Produkcyjno-Handlowe Def-Pol sp. z o.o. | $809,644.85 | def-pol.pl | ||
| Medical Protection sp. z o.o. sp. k. | $342,876.33 | medicalprotection.pl | ||
| Polmask sp. z o.o. | $268,958.55 | polmask.pl | ||
| Lemon Polska sp. z o.o. | $222,475.86 | lemonpolska.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-05-16 | Address change (Ul. Williama Heerleina Lindleya 16, 02-013, Warszawa → Aleja Jana Pawła II 27, 00-867, Warszawa) | |
| 2022-05-16 | PKD change (Removed: 4 codes; Added: 3 codes) | |
| 2020-04-24 | Entered in the register |
FAQ
Last updated: 2026-07-16